Log in

NASDAQ:TECHBIO-TECHNE Earnings Date, Estimates & History

$266.55
-1.32 (-0.49 %)
(As of 08/6/2020 04:00 PM ET)
Add
Compare
Today's Range
$262.34
Now: $266.55
$271.21
50-Day Range
$250.87
MA: $267.99
$282.96
52-Week Range
$155.17
Now: $266.55
$286.68
Volume122,028 shs
Average Volume171,782 shs
Market Capitalization$10.19 billion
P/E Ratio46.04
Dividend Yield0.48%
Beta1.12

Earnings

BIO-TECHNE (NASDAQ:TECH) Earnings Information

BIO-TECHNE last released its quarterly earnings results on August 4th, 2020. The biotechnology company reported $1.00 EPS for the quarter, topping analysts' consensus estimates of $0.57 by $0.43. The business had revenue of $175.83 million for the quarter, compared to analyst estimates of $165.70 million. Its quarterly revenue was down 8.3% compared to the same quarter last year. BIO-TECHNE has generated $0.00 earnings per share over the last year and currently has a price-to-earnings ratio of 46.0. BIO-TECHNE has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 3rd, 2020 based off prior year's report dates.

BIO-TECHNE Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BIO-TECHNE (NASDAQ:TECH) Earnings Estimates

2020 EPS Consensus Estimate: $3.70
2021 EPS Consensus Estimate: $4.75
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201$0.95$0.95$0.95
Q2 20201$1.00$1.00$1.00
Q3 20201$0.97$0.97$0.97
Q4 20201$0.78$0.78$0.78
Q1 20211$1.07$1.07$1.07
Q2 20211$1.14$1.14$1.14
Q3 20211$1.23$1.23$1.23
Q4 20211$1.31$1.31$1.31

BIO-TECHNE (NASDAQ TECH) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/3/2020
(Estimated)
       
8/4/20206/30/2020$0.57$1.00$0.26$165.70 million$175.83 millionTranscript
4/30/20203/31/2020$1.15$1.39$1.52$182.32 million$194.70 millionTranscript
2/4/2020Q2 2020$1.13$1.08($1.40)$191.34 million$184.93 millionTranscript
10/29/2019Q1 2020$0.92$1.06$1.39$179.38 million$183.24 millionTranscript
8/6/2019Q4 2019$1.17$1.25$1.68$196.37 million$191.66 millionListen
4/30/20193/31/2019$0.94$1.21$0.99$183.92 million$184.86 millionN/A
2/5/201912/31/2018$0.98$1.06$1.39$171.39 million$174.50 millionListen
10/30/20189/30/2018$0.95$0.98$1.11$162.34 million$163.00 millionN/A
8/7/2018Q4 2018$1.29$1.34$1.13$176.24 million$180.25 millionN/A
5/2/2018Q3 2018$1.14$1.21$1.74$163.43 million$164.00 millionN/A
2/6/2018Q2 2018$0.92$1.02$0.53$145.93 million$154.15 millionTranscript
10/31/2017Q1 2018$0.82$0.90$1.22$142.37 million$144.61 millionN/A
8/8/2017Q4 2017$0.99$1.09$1.27$150.25 million$156.60 millionListen
5/2/2017Q3 2017$0.93$0.97$1.21$142.83 million$144.04 millionListen
2/7/2017Q2 2017$0.79$0.74$1.31$134.74 million$131.80 millionListen
10/31/2016Q1 2017$0.75$0.78$1.13$127.47 million$130.60 millionListen
8/17/2016Q4 2016$0.88$0.87$1.05$129.23 million$134.80 millionListen
5/3/2016Q3 2016$0.85$0.97$1.13$122.65 million$131.00 millionN/A
2/2/2016Q2 2016$0.82$0.82$0.95$118.59 million$120.90 millionN/A
10/28/2015Q1 2016$0.85$0.75$0.89$116.91 million$12.40 millionListen
8/6/2015Q4 2015$0.87$0.87$1.03$116.85 million$117.70 millionN/A
5/5/2015Q3 2015$0.91$0.86$1.07$119.30 million$114.20 millionN/A
2/3/2015Q2 2015$0.86$0.82$0.75$112.73 million$111.90 millionN/A
10/28/2014Q1 2015$0.87$0.85$1.06$108.65 million$108.50 millionN/A
8/11/2014Q4 2014$0.85$0.88$1.04$91.80 million$92.50 millionN/A
4/28/2014Q3 2014$0.89$0.94$1.03$92.50 million$95.60 millionTranscript
2/4/2014Q2 2014$0.80$0.75$0.82$84.79 million$84.00 millionTranscript
10/29/2013Q1 2014$0.80$0.83$0.92$82.36 million$85.70 millionListen
8/6/2013Q4 2013$0.84$0.82$0.87$79.71 million$79.50 millionN/A
4/30/2013Q3 2013$0.89$0.88$0.86$84.00 million$81.00 millionN/A
2/5/2013Q2 2013$0.77$0.74$76.40 million$75.10 millionListen
10/23/2012$0.79$0.75Listen
7/31/2012$0.85$0.80N/A
5/1/2012$0.89$0.90Transcript
1/31/2012$0.79$0.76N/A
10/25/2011$0.84$0.81N/A
8/2/2011$0.76$0.76N/A
5/3/2011$0.80$0.84N/A
2/1/2011$0.68$0.71N/A
10/26/2010Q1 2011$0.73$0.71$0.71N/A
8/3/2010Q4 2010$0.71$0.69$0.69N/A
5/4/2010Q3 2010$0.79$0.87$0.87N/A
2/2/2010Q2 2010$0.68$0.66$0.66N/A
10/28/2009Q1 2010$0.70$0.72$0.72N/A
8/4/2009Q4 2009$0.69$0.68$0.68N/A
4/28/2009Q3 2009$0.72$0.74$0.74N/A
2/3/2009Q2 2009$0.64$0.62$0.62N/A
10/22/2008Q1 2009$0.66$0.74$0.74N/A
8/5/2008Q4 2008$0.67$0.70$0.70N/A
4/29/2008Q3 2008$0.66$0.76$0.76N/A
1/29/2008Q2 2008$0.54$0.60$0.60N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.